Call for head of stem cell institute to resign
By San Francisco Chronicle,
San Francisco Chronicle
| 01. 19. 2006
An East Bay biotechnology watchdog group on Wednesday called for the resignation of Robert Klein, chairman of the Proposition 71 stem cell agency known as the California Institute for Regenerative Medicine.
Jesse Reynolds, stem cell specialist at the group, the Center for Genetics and Society, said the Prop. 71 enterprise needs a fresh start after a year in business, even though the institute has been mired in litigation that has blocked its ability to distribute grant money into stem cell research.
Klein said through a spokeswoman that he intended to stay.
The Oakland advocacy group gave the California Institute for Regenerative Medicine an overall grade of "C-minus" in a 32-page report examining how Prop. 71 has been implemented. Most of the critique covered familiar complaints about inadequate governance and the need for more health protections for women who may be recruited as stem cell research subjects.
Klein, a Stanford-educated lawyer and real estate developer, drafted the proposition and led the 2004 election campaign after he became convinced that California needed to advance stem cell research to cure common diseases. Prop...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...